Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Gutniak

Showing results (11-20 of 28) with videos related to

Pageof 3
Sort By:
The European Journal of Surgery = Acta Chirurgica|November 1, 1993
Development of postoperative insulin resistance is associated with the magnitude of operationA Thorell, S Efendic, M Gutniak, et al.
Acta Endocrinologica|December 1, 1981
Insulin, glucagon and somatostatin in the perfused rat pancreas and the effects of HB 699 (4-(2-(5-chloro-2-metoxy-benzamido)-ethyl)-benzoic acid)S Efendić, F Enzmann, M Gutniak, et al.
The British Journal of Surgery|January 1, 1994
Insulin resistance after abdominal surgeryA Thorell, S Efendic, M Gutniak, et al.
Journal of the American College of Surgeons|April 1, 1994
Glucose infusion instead of preoperative fasting reduces postoperative insulin resistanceO Ljungqvist, A Thorell, M Gutniak, et al.
Diabetes Research and Clinical Practice|September 1, 1991
Effects of cholecystokinin (CCK)-8, CCK-33, and gastric inhibitory polypeptide (GIP) on basal and meal-stimulated pancreatic hormone secretion in manB Ahrén, M Pettersson, K Uvnäs-Moberg, et al.
The American Journal of Clinical Nutrition|September 12, 1998
Glucagon-like peptide 1 increases the period of postprandial satiety and slows gastric emptying in obese menE Näslund, M Gutniak, S Skogar, et al.
The New England Journal of Medicine|May 14, 1992
Antidiabetogenic effect of glucagon-like peptide-1 (7-36)amide in normal subjects and patients with diabetes mellitusM Gutniak, C Orskov, J J Holst, et al.
Diabetologia|December 1, 1986
Sulfonylurea-induced inhibition of glucagon secretion from the perfused rat pancreas: evidence for a direct, non-paracrine effectC G Ostenson, A Nylén, V Grill, et al.
The Journal of Clinical Investigation|August 26, 1998
Inhibitory effect of glucagon-like peptide-1 on small bowel motility. Fasting but not fed motility inhibited via nitric oxide independently of insulin and somatostatinT Tolessa, M Gutniak, J J Holst, et al.
Digestive Diseases and Sciences|October 28, 1998
Glucagon-like peptide-1 retards gastric emptying and small bowel transit in the rat: effect mediated through central or enteric nervous mechanismsT Tolessa, M Gutniak, J J Holst, et al.
Pageof 3

Showing results (11-20 of 28) with videos related to

Sort By:
Pageof 3
The European Journal of Surgery = Acta Chirurgica|November 1, 1993
Development of postoperative insulin resistance is associated with the magnitude of operationA Thorell, S Efendic, M Gutniak, et al.
Acta Endocrinologica|December 1, 1981
Insulin, glucagon and somatostatin in the perfused rat pancreas and the effects of HB 699 (4-(2-(5-chloro-2-metoxy-benzamido)-ethyl)-benzoic acid)S Efendić, F Enzmann, M Gutniak, et al.
The British Journal of Surgery|January 1, 1994
Insulin resistance after abdominal surgeryA Thorell, S Efendic, M Gutniak, et al.
Journal of the American College of Surgeons|April 1, 1994
Glucose infusion instead of preoperative fasting reduces postoperative insulin resistanceO Ljungqvist, A Thorell, M Gutniak, et al.
Diabetes Research and Clinical Practice|September 1, 1991
Effects of cholecystokinin (CCK)-8, CCK-33, and gastric inhibitory polypeptide (GIP) on basal and meal-stimulated pancreatic hormone secretion in manB Ahrén, M Pettersson, K Uvnäs-Moberg, et al.
The American Journal of Clinical Nutrition|September 12, 1998
Glucagon-like peptide 1 increases the period of postprandial satiety and slows gastric emptying in obese menE Näslund, M Gutniak, S Skogar, et al.
The New England Journal of Medicine|May 14, 1992
Antidiabetogenic effect of glucagon-like peptide-1 (7-36)amide in normal subjects and patients with diabetes mellitusM Gutniak, C Orskov, J J Holst, et al.
Diabetologia|December 1, 1986
Sulfonylurea-induced inhibition of glucagon secretion from the perfused rat pancreas: evidence for a direct, non-paracrine effectC G Ostenson, A Nylén, V Grill, et al.
The Journal of Clinical Investigation|August 26, 1998
Inhibitory effect of glucagon-like peptide-1 on small bowel motility. Fasting but not fed motility inhibited via nitric oxide independently of insulin and somatostatinT Tolessa, M Gutniak, J J Holst, et al.
Digestive Diseases and Sciences|October 28, 1998
Glucagon-like peptide-1 retards gastric emptying and small bowel transit in the rat: effect mediated through central or enteric nervous mechanismsT Tolessa, M Gutniak, J J Holst, et al.
Pageof 3